enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
3.830
+0.040 (1.06%)
Aug 1, 2025, 4:00 PM - Market closed
Revance Therapeutics Market Cap
enGene Holdings has a market cap or net worth of $195.73 million as of August 1, 2025. Its market cap has decreased by -50.81% in one year.
Market Cap
195.73M
Enterprise Value
3.70M
1-Year Change
-50.81%
Ranking
Category
Stock Price
$3.83
Market Cap Chart
Since February 1, 2022, enGene Holdings's market cap has increased from $155.91M to $195.73M, an increase of 25.54%. That is a compound annual growth rate of 6.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 193.69M | -42.86% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.35B |
| Johnson & Johnson | 402.82B |
| AbbVie | 334.40B |
| UnitedHealth Group | 241.34B |
| AstraZeneca | 236.88B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 223.66B |
| Novo Nordisk | 221.96B |